20
203780.KO MiraeAsset TIGER NASDAQ BIO ETF
- KRW
No recent price
- Total assets
- 105B
- Expense ratio
- 0.48%
- Dividend yield
- 0.00%
- 1-year return
- +23.86%
- Holdings
- 10
- Since
- 2014
Fund data as reported by the issuer, updated Nov 4, 2026. Total assets are in the fund's base currency.
What does 203780.KO invest in?
Tracks Morningstar Gbl Health NR USD- Mostly US stocks (95.3%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (100.3%)
- Top 3 holdings: 37.9% of the fund
Asset allocation
- US stocks 95.3%
- Non-US stocks 4.8%
- Cash 1.9%
Top holdings
- iShares Biotechnology ETF 25.76%
- Gilead Sciences Inc 6.08%
- Amgen Inc 6.05%
- Biogen Inc 5.78%
- Celgene Corporation 5.35%
MiraeAsset TIGER NASDAQ BIO ETF performance
Sharpe ratio 1.11- This year
- +15.30%
- 1 year
- +23.86%
- 3 years
- +23.14%
- 5 years
- +9.73%
Volatility 20.7% over 1 year and 18.8% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
203780.KO price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
MiraeAsset TIGER NASDAQ BIO ETF top holdings
64.0% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| iShares Biotechnology ETF IBB.US | - | United States | 25.76% |
| Gilead Sciences Inc GILD.US | Healthcare | United States | 6.08% |
| Amgen Inc AMGN.US | Healthcare | United States | 6.05% |
| Biogen Inc BIIB.US | Healthcare | United States | 5.78% |
| Celgene Corporation CELG.US | Healthcare | United States | 5.35% |
| Illumina Inc ILMN.US | Healthcare | United States | 4.71% |
| Vertex Pharmaceuticals Inc VRTX.US | Healthcare | United States | 3.00% |
| Regeneron Pharmaceuticals Inc REGN.US | Healthcare | United States | 2.82% |
| Alexion Pharmaceuticals Inc ALXN.US | Healthcare | United States | 2.75% |
| Viatris Inc MYL.US | Healthcare | United States | 1.71% |
203780.KO sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
203780.KO regional exposure
- North America100.3%
- Europe Developed2.1%
- United Kingdom1.9%
- Asia Emerging0.1%
- Australasia0.1%
- Africa/Middle East0.0%
- Asia Developed0.0%
Share of the stocks in the fund.
Company size
Average market cap 40.4T- Mega cap0.6%
- Big cap31.1%
- Medium cap30.5%
- Small cap22.2%
- Micro cap10.1%
MiraeAsset TIGER NASDAQ BIO ETF fund profile
- Fund name
- MiraeAsset TIGER NASDAQ BIO ETF
- Ticker
- 203780.KO
- Exchange
- Korea Stock Exchange
- Index tracked
- Morningstar Gbl Health NR USD
- Category
- Healthcare Equity
- Domicile
- Korea, Republic Of
- Inception date
- Aug 26, 2014
- Trading currency
- KRW
- Expense ratio
- 0.48%
- Dividends paid
- Quarterly